Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Conditions: Type 2 Diabetes; Chronic Kidney Diseases
Interventions: Diagnostic Test: BP; Diagnostic Test: HbA1c; Behavioral: PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD
Sponsors: Duke University; National Institute on Minority Health and Health Disparities (NIMHD)
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 25, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments